Find Trimagnesium Dicitrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

0

Canada

0

Australia

0

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

190RELATED EXCIPIENT COMPANIES

299EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Magnesium citrate dibasic, anhydrous, 144-23-0, 7779-25-1, Magnesiumcitrate(x:1), Magnesium citrate(x:1), Akos028109527
Molecular Formula
C6H6MgO7
Molecular Weight
214.41  g/mol
InChI Key
DIXGJWCZQHXZNR-UHFFFAOYSA-L

Trimagnesium Dicitrate
1 2D Structure

Trimagnesium Dicitrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
magnesium;2-(carboxymethyl)-2-hydroxybutanedioate
2.1.2 InChI
InChI=1S/C6H8O7.Mg/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+2/p-2
2.1.3 InChI Key
DIXGJWCZQHXZNR-UHFFFAOYSA-L
2.1.4 Canonical SMILES
C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.[Mg+2]
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Magnesium Citrate Dibasic, Anhydrous

2. 144-23-0

3. 7779-25-1

4. Magnesiumcitrate(x:1)

5. Magnesium Citrate(x:1)

6. Akos028109527

7. J-007935

2.3 Create Date
2012-08-08
3 Chemical and Physical Properties
Molecular Weight 214.41 g/mol
Molecular Formula C6H6MgO7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count7
Rotatable Bond Count3
Exact Mass213.9963942 g/mol
Monoisotopic Mass213.9963942 g/mol
Topological Polar Surface Area138 Ų
Heavy Atom Count14
Formal Charge0
Complexity234
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2

API SUPPLIERS

read-more
read-more

01

Dr. Paul Lohmann GmbH & Co. KGaA

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDr. Paul Lohmann® provides premium mineral salts backed by 140+ years of innovation, quality manufacturing, and global expertise.

Flag Germany
Digital Content Digital Content
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

02

Jai Radhe Sales

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJai Radhe Sales is your partner for all your sourcing needs.

Flag India
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jai Radhe Sales

03

Dr. Paul Lohmann GmbH & Co. KGaA

Germany

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDr. Paul Lohmann® provides premium mineral salts backed by 140+ years of innovation, quality manufacturing, and global expertise.

Flag Germany
Digital Content Digital Content
USDMF CEP/COS arrow-down JDMF EU-WC NDC KDMF VMF Others AUDIT
Company Banner

04

Muby Chem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Muby Chem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

05

Anmol Chemicals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Anmol Chemicals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCarrow-down NDC KDMF VMF Others AUDIT
blank

06

Muby Chem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Muby Chem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

07

Vasa Pharmachem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Vasa Pharmachem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Vasa Pharmachem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Vasa Pharmachem

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

09

Jost Chemical

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

Jost Chemical

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

10

India Phosphate

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

AOCS Annual Meeting
Not Confirmed
arrow

India Phosphate

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
AOCS Annual Meeting
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Magnesium Citrate USP

Date of Issue : 2026-01-12

Valid Till : 2028-02-02

Written Confirmation Number : WC-0518

Address of the Firm : J-63, ROAD NO. U-6, MIDC Taloja, Taluka: Panvel, Raigad- 410208, Maharashtra Sta...

blank

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Magnesium Citrate USP

Date of Issue : 2026-01-12

Valid Till : 2028-02-02

Written Confirmation Number : WC-0518

Address of the Firm : J-63, ROAD NO. U-6, MIDC Taloja, Taluka: Panvel, Raigad- 410208, Maharashtra Sta...

blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Magnesium Citrate USP

Date of Issue : 2026-03-27

Valid Till : 2029-11-14

Written Confirmation Number : WC-0573

Address of the Firm : Unit-lll, 19 & 19B, SIPCOT Industrial Complex, Hosur-635126, Tamil Nadu, India

blank

04

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Magnesium Citrate EP

Date of Issue : 2026-03-27

Valid Till : 2029-11-14

Written Confirmation Number : WC-0573

Address of the Firm : Unit-lll, 19 & 19B, SIPCOT Industrial Complex, Hosur-635126, Tamil Nadu, India

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Magnesium Citrate Ph.Eur./USP

Date of Issue : 2025-07-22

Valid Till : 2028-07-07

Written Confirmation Number : WC-0104

Address of the Firm : 124, 125 and 126, SIPCOT Industrial Complex, Hosur -635126, Tamil Nadu, India

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Drugs in Development

read-more
read-more
  • Development Update

Details:

MTP-101P is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pitt-Hopkins syndrome.


Lead Product(s): MTP-101P,Vancomycin Hydrochloride,Trimagnesium Dicitrate,Antacid

Therapeutic Area: Rare Diseases and Disorders Brand Name: Undisclosed

Study Phase: Phase IIProduct Type: Undisclosed

Sponsor: Pitt Hopkins Research Foundation

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable March 20, 2024

blank

01

Gut-Brain-Axis Therapeutics

Country
arrow
Arvo
Not Confirmed

Gut-Brain-Axis Therapeutics

Country
arrow
Arvo
Not Confirmed

Details : MTP-101P is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pitt-Hopkins syndrome.

Product Name : Undisclosed

Product Type : Undisclosed

Upfront Cash : Inapplicable

March 20, 2024

blank
  • Development Update

Details:

Vitamin K1 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Calciphylaxis.


Lead Product(s): Vitamin K1,Sodium Chloride,Trimagnesium Dicitrate,Sodium Thiosulfate

Therapeutic Area: Rare Diseases and Disorders Brand Name: Undisclosed

Study Phase: Phase IIIProduct Type: Vitamins/Minerals/Inorganic Salts

Sponsor: Australasian Kidney Trials Network | Northern Care Alliance NHS Foundation Trust | Waitemata District Health Board

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 24, 2021

blank

02

University of Sydney

Country
arrow
Arvo
Not Confirmed

University of Sydney

Country
arrow
Arvo
Not Confirmed

Lead Product(s) : Vitamin K1,Sodium Chloride,Trimagnesium Dicitrate,Sodium Thiosulfate

Therapeutic Area : Rare Diseases and Disorders

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Australasian Kidney Trials Network | Northern Care Alliance NHS Foundation Trust | Waitemata District Health Board

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Vitamin K1 is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Calciphylaxis.

Product Name : Undisclosed

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

August 24, 2021

blank
  • Development Update

Details:

Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Restless Legs Syndrome.


Lead Product(s): Trimagnesium Dicitrate,Inapplicable

Therapeutic Area: Neurology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Vitamins/Minerals/Inorganic Salts

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 08, 2020

blank

03

OSF Healthcare System

Country
arrow
Arvo
Not Confirmed

OSF Healthcare System

Country
arrow
Arvo
Not Confirmed

Details : Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Restless Legs Syndrome.

Product Name : Undisclosed

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

July 08, 2020

blank
  • Development Update

Details:

Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Vascular Stiffness.


Lead Product(s): Trimagnesium Dicitrate,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Vitamins/Minerals/Inorganic Salts

Sponsor: Nedmag Industries Mining and Manufacturing B.V.

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 15, 2018

blank

04

University Medical Center Groningen

Country
arrow
Arvo
Not Confirmed

University Medical Center Groningen

Country
arrow
Arvo
Not Confirmed

Lead Product(s) : Trimagnesium Dicitrate,Inapplicable

Therapeutic Area : Cardiology/Vascular Diseases

Highest Development Status : Undisclosed

Partner/Sponsor/Collaborator : Nedmag Industries Mining and Manufacturing B.V.

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Vascular Stiffness.

Product Name : Undisclosed

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

August 15, 2018

blank
  • Development Update

Details:

Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.


Lead Product(s): Trimagnesium Dicitrate,Dulcolax Tablets

Therapeutic Area: Undisclosed Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Vitamins/Minerals/Inorganic Salts

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable August 11, 2017

blank

05

LifeBridge Health

Country
arrow
Arvo
Not Confirmed

LifeBridge Health

Country
arrow
Arvo
Not Confirmed

Details : Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

Product Name : Undisclosed

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

August 11, 2017

blank
  • Development Update

Details:

Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus.


Lead Product(s): Trimagnesium Dicitrate,Inapplicable

Therapeutic Area: Endocrinology Brand Name: Undisclosed

Study Phase: UndisclosedProduct Type: Vitamins/Minerals/Inorganic Salts

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 23, 2016

blank

06

Protina Pharmazeutische GmbH

Country
arrow
Arvo
Not Confirmed

Protina Pharmazeutische GmbH

Country
arrow
Arvo
Not Confirmed

Details : Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Diabetes Mellitus.

Product Name : Undisclosed

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

December 23, 2016

blank
  • Development Update

Details:

Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Essential Hypertension.


Lead Product(s): Trimagnesium Dicitrate,Inapplicable

Therapeutic Area: Cardiology/Vascular Diseases Brand Name: Undisclosed

Study Phase: Phase I/ Phase IIProduct Type: Vitamins/Minerals/Inorganic Salts

Sponsor: Undisclosed

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 04, 2016

blank

07

RMJ Holdings

Country
arrow
Arvo
Not Confirmed

RMJ Holdings

Country
arrow
Arvo
Not Confirmed

Details : Magnesium Citrate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase I/ phase II clinical studies for the treatment of Essential Hypertension.

Product Name : Undisclosed

Product Type : Vitamins/Minerals/Inorganic Salts

Upfront Cash : Inapplicable

July 04, 2016

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Solubilizers

read-more
read-more

Taste Masking

read-more
read-more

Topical

read-more
read-more

Co-Processed Excipients

read-more
read-more

API Stability Enhancers

read-more
read-more

Parenteral

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Empty Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Vegetarian Capsules

read-more
read-more

Emulsifying Agents

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Looking for 144-23-0 / Trimagnesium Dicitrate API manufacturers, exporters & distributors?

Trimagnesium Dicitrate manufacturers, exporters & distributors 1

87

PharmaCompass offers a list of Trimagnesium Dicitrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Trimagnesium Dicitrate manufacturer or Trimagnesium Dicitrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trimagnesium Dicitrate manufacturer or Trimagnesium Dicitrate supplier.

API | Excipient name

Trimagnesium Dicitrate

Synonyms

Magnesium citrate dibasic, anhydrous, 144-23-0, 7779-25-1, Magnesiumcitrate(x:1), Magnesium citrate(x:1), Akos028109527

Cas Number

144-23-0

Trimagnesium Dicitrate Manufacturers

A Trimagnesium Dicitrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trimagnesium Dicitrate, including repackagers and relabelers. The FDA regulates Trimagnesium Dicitrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trimagnesium Dicitrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Trimagnesium Dicitrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Trimagnesium Dicitrate Suppliers

A Trimagnesium Dicitrate supplier is an individual or a company that provides Trimagnesium Dicitrate active pharmaceutical ingredient (API) or Trimagnesium Dicitrate finished formulations upon request. The Trimagnesium Dicitrate suppliers may include Trimagnesium Dicitrate API manufacturers, exporters, distributors and traders.

click here to find a list of Trimagnesium Dicitrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Trimagnesium Dicitrate USDMF

A Trimagnesium Dicitrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Trimagnesium Dicitrate active pharmaceutical ingredient (API) in detail. Different forms of Trimagnesium Dicitrate DMFs exist exist since differing nations have different regulations, such as Trimagnesium Dicitrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Trimagnesium Dicitrate DMF submitted to regulatory agencies in the US is known as a USDMF. Trimagnesium Dicitrate USDMF includes data on Trimagnesium Dicitrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trimagnesium Dicitrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Trimagnesium Dicitrate suppliers with USDMF on PharmaCompass.

Trimagnesium Dicitrate CEP

A Trimagnesium Dicitrate CEP of the European Pharmacopoeia monograph is often referred to as a Trimagnesium Dicitrate Certificate of Suitability (COS). The purpose of a Trimagnesium Dicitrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Trimagnesium Dicitrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Trimagnesium Dicitrate to their clients by showing that a Trimagnesium Dicitrate CEP has been issued for it. The manufacturer submits a Trimagnesium Dicitrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Trimagnesium Dicitrate CEP holder for the record. Additionally, the data presented in the Trimagnesium Dicitrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Trimagnesium Dicitrate DMF.

A Trimagnesium Dicitrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Trimagnesium Dicitrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Trimagnesium Dicitrate suppliers with CEP (COS) on PharmaCompass.

Trimagnesium Dicitrate WC

A Trimagnesium Dicitrate written confirmation (Trimagnesium Dicitrate WC) is an official document issued by a regulatory agency to a Trimagnesium Dicitrate manufacturer, verifying that the manufacturing facility of a Trimagnesium Dicitrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trimagnesium Dicitrate APIs or Trimagnesium Dicitrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Trimagnesium Dicitrate WC (written confirmation) as part of the regulatory process.

click here to find a list of Trimagnesium Dicitrate suppliers with Written Confirmation (WC) on PharmaCompass.

Trimagnesium Dicitrate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trimagnesium Dicitrate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Trimagnesium Dicitrate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Trimagnesium Dicitrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Trimagnesium Dicitrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trimagnesium Dicitrate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Trimagnesium Dicitrate suppliers with NDC on PharmaCompass.

Trimagnesium Dicitrate GMP

Trimagnesium Dicitrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Trimagnesium Dicitrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Trimagnesium Dicitrate GMP manufacturer or Trimagnesium Dicitrate GMP API supplier for your needs.

Trimagnesium Dicitrate CoA

A Trimagnesium Dicitrate CoA (Certificate of Analysis) is a formal document that attests to Trimagnesium Dicitrate's compliance with Trimagnesium Dicitrate specifications and serves as a tool for batch-level quality control.

Trimagnesium Dicitrate CoA mostly includes findings from lab analyses of a specific batch. For each Trimagnesium Dicitrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Trimagnesium Dicitrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Trimagnesium Dicitrate EP), Trimagnesium Dicitrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trimagnesium Dicitrate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty